Awaiting product image

Article: Pirtobrutinib (Jaypirca®) EMA approved for the treatment of patients with relapsed/refractory mantle cell lymphoma who previously received a BTK inhibitor

€3.03

SKU: product-article-44227 Category:

Description

Pirtobrutinib (Jaypirca®) EMA approved for the treatment of patients with relapsed/refractory mantle cell lymphoma who previously received a BTK inhibitor

Reviews

There are no reviews yet.

Be the first to review “Article: Pirtobrutinib (Jaypirca®) EMA approved for the treatment of patients with relapsed/refractory mantle cell lymphoma who previously received a BTK inhibitor”

Related products